At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...

BIO Business Solutions ® is the largest cost savings purchasing program for the biotech industry operated by the Biotechnology Innovation Organization (BIO). With more than half a billion in annual ...

The Biotechnology Innovation Organization (BIO) released the following statement in response to a bipartisan letter signed by 21 members of the U.S. House of Representatives. Led by Reps. Randy ...

How can BIO help you make your mark? A membership with BIO gives you a powerful voice to help advance your science and enact meaningful change.

Joining a BIO policy committee is the best way to shape BIO’s domestic and international policies, participate in public outreach, and stay informed. Committee participation is open to all employees ...

A 2023 biotech breakthrough: CRISPR gene-editing therapy offers new hope for 100,000 Americans with sickle cell. Hear from CASGEVY's creators and patient advocates in this episode. Biotech tackles ...

A collaborative initiative to advance corporate board diversity through partnerships and more.

Here are a few highlights from the policymakers and regulators who spoke at the event. We look forward to seeing you next year!

T-Cure Bioscience, Inc. is an innovative immuno-oncology company committed to delivering effective and durable cell therapies for the treatment of cancer. The Company focuses on isolating high avidity ...

BIO is in search of dynamic, professional candidates possessing the expertise and education outlined in the job titles listed below. If you are interested in working at BIO, please visit our current ...

"BIO is a crucial trade group representing all biotech and biopharma companies with influence on policies affecting our business and patients with rare diseases in the U.S. Through our participation ...